Untested Ebola drug given to patients in Sierra Leone causes UK walkout
Use of amiodarone heart drug at Lakka centre in Freetown deemed ‘reckless’ by scientist as 14 medical staff withdraw over safety fears
Ebola patients at a treatment centre in Sierra Leone have been given a heart drug that is untested against the virus in animals and humans, a move that has been deemed reckless by one senior scientist and has prompted UK medical staff at the centre to leave.
A 14-strong team of British doctors, nurses and paramedics stopped working at the Lakka treatment centre in Freetown because of their concerns over what they considered the experimental and potentially dangerous use of the drug, and other safety issues.
More From Around the Web
Check out these Articles
- Trevor Kletz obituary
- NABP, Stakeholders Release Consensus Document on the Challenges and “Red ...
- ‘Homely’ Boots treats its staff like red revolutionaries | Nick...
- Pfizer boss admits Astra move would cost jobs and cut R&D spending
- Drug Discovery 2017 Highlights 8 Key Themes in the Industry
- A Lay Person’s Guide to the Hobby Lobby Decision
- ABR Launches New Mycoplasma Testing Services
- Jane Rohlf, MD & Premier Research Join Wake Research: New Investigation...
- Owen Smith: Corbyn is exploiting my former work in pharmaceuticals
- Active Pharmaceutical Ingredient Market to Witness Growth, Increasing Proli...
- Interviews Released on Antibiotic Resistance with Danestat Consulting, John...
- Chinese Pharma Growth Slows, But with Unchanged Long Term Positive View
- Texas to Implement New PIC Requirements for Nonresident Pharmacies